Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2002
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
L03AB07
|
| gptkbp:brand |
gptkb:interferon_beta-1a
|
| gptkbp:CASNumber |
220581-49-7
|
| gptkbp:contraindication |
gptkb:liver_disease
severe depression |
| gptkbp:drugClass |
gptkb:insulin
|
| gptkbp:form |
solution for injection
44 mcg 22 mcg |
| gptkbp:frequency |
three times per week
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rebif
|
| gptkbp:indication |
relapsing forms of multiple sclerosis
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:EMD_Serono
gptkb:Merck_KGaA |
| gptkbp:mechanismOfAction |
immunotherapy
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
gptkb:depression
injection site reaction flu-like symptoms liver enzyme elevation |
| gptkbp:storage |
refrigerated
|
| gptkbp:UNII |
P18A0J2Y9T
|
| gptkbp:usedFor |
multiple sclerosis
|
| gptkbp:bfsParent |
gptkb:默克
gptkb:Merck |
| gptkbp:bfsLayer |
5
|